EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Artificial intelligence in digital mental health technology: Considerations for regulation

Sarah Pais iD, Holly Coole, Janagan Alagarajah, Aislinn Gómez Bergin

DIGITAL HEALTH · 2026-02 · 12

DOI: 10.1177/20552076261467804 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift DIGITAL HEALTH, online erschienen am 05.08.2026. Verfasst von Sarah Pais und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medicines and Healthcare products Regulatory Agency, London, UK. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Wellcome Trust, Wellcome through the Effective Regulation and Evaluation of Digital Mental Health Technologies, Engineering and Physical Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial intelligence (AI) is being introduced into all aspects of life with notable adoption seen in health care and systems and growing utility in the domain of digital mental health technology (DMHT). The Medicines and Healthcare products Regulatory Agency and the National Institute for Health and Care Excellence in the UK are together exploring the regulation and evaluation of DMHT through a Wellcome-funded project. As part of this initiative, a symposium was held to bring together experts from across the AI and DMHT sector representing a breadth of disciplines, to share insights and inform the project. This review presents a reflection of the key opportunities and challenges of AI in DMHT with a focus on medical device regulation, distilling the main themes from the symposium. To facilitate responsible and agile regulation enabling access to high quality, safe, and effective medical products, regulators will need to continually adapt and develop, with new processes, guidance, initiatives and forums to fully engage in this innovative, exponentially developing field.

Schlagwörter

Stichwörter der Autor:innen

Artificial intelligence < GeneralDigital < GeneralDigital health < GeneralMental health < PsychologyTechnology < General

Autor:innen und Institutionen

  • Medicines and Healthcare products Regulatory Agency, London, UK.
  • NHS England, London, UK.
  • School of Computer Science, University of Nottingham, Nottingham, UK.

ORCID-Profile: Sarah Pais

Förderung

  • Wellcome Trust
  • Wellcome through the Effective Regulation and Evaluation of Digital Mental Health Technologies
  • Engineering and Physical Sciences Research Council
  • Ai UK

Zitieren

APA

Pais, S., Coole, H., Alagarajah, J., & Bergin, A. G. (2026). Artificial intelligence in digital mental health technology: Considerations for regulation. DIGITAL HEALTH, 12. https://doi.org/10.1177/20552076261467804

Vancouver

Pais S, Coole H, Alagarajah J, Bergin AG. Artificial intelligence in digital mental health technology: Considerations for regulation. DIGITAL HEALTH. 2026;12. doi:10.1177/20552076261467804

BibTeX
@article{Pais2026,
  author = {Pais, Sarah and Coole, Holly and Alagarajah, Janagan and Bergin, Aislinn Gómez},
  title = {Artificial intelligence in digital mental health technology: Considerations for regulation},
  journal = {DIGITAL HEALTH},
  year = {2026},
  volume = {12},
  doi = {10.1177/20552076261467804}
}
Kostenlos starten →